References
- El Nahas AM. Glomeular sclerosis: Insights into Pathogenesis and Treatment. Nephrol Dial Transplant 1989; 4: 843–853
- Tolins JP, Raij L. Angiotansin converting enzyme inhibitors and progression of chronic renal failure. Kidney Inn 1990; 38: S118–S122, suppl 30
- Djukanovic Lj, Pljesa S, Bukvic D, Milosavljevic M, Calic N, Stojimirovic B, Vujic D, Perunicic S, Marie Jovanovic D, Lezaic V. Retardation of chronic renal failure progression. Mak Med Pregled 1994; 173–178, suppl 14
- Djukanovic Lj, Susic D, Jovanovic D, Varagic J, Jovanovic Dj, Starcevic A, Kartaljevic C, Bogdanovic C. Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats. Isr J Med Sci 1994; 30: 742–746
- Raij L, Azar S, Keane W. Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137–143
- Fajardo LF, Eltringham JR, Stewart JR, Klauber MR. Adriamycin nephrotoxiciry. Lab Invest 1980; 43(3)242–253
- Fogo A, Yoshida Y, Click AD, Homma T, Ichikawa I. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 1988; 82: 322–330
- Maschio C. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?. Nephron 1994; 67: 257–262
- Cartwright ME, Jaenke RS. Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy. Lab Invest 1988; 59: 492–499
- Fogo A. Intemephron heterogeneity of growth factors and sclerosis. Kidney Int 1994; 45: S24–S26, suppl 45
- Pojdamy E, Rathaus M, Shapira J, Kariv N, Pomeranz A, Zadok S, Bemheim J. Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats. Nephron 1990; 55: 196–202
- Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesion. Kidney Int 1991; 40: 195–202
- Rodicio JL, Alcazar JM, Ruilope M. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 1990; 38: 590–594
- Mann JFE, Reisch C, Ritz E. Use of angiotensin converting enzyme inhibitors for the preservation of kidney function. Nephron 1990; 55: 38–42, suppl 1
- Hansson L. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate. Cardiology 1995; 86: 30–33, suppl 1